NASDAQ · Financial Statements
Dare Bioscience, Inc. (DARE) Financial Statements
$0.77
NASDAQ: DARE
Market Cap $11.59M
Overview Financials Dividend Dare Bioscience, Inc. most recently reported annual revenue of $1.0M, net profit of $-13.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $10.0M $3.0M $0 $1.0M Operating Profit $-39.0M $-31.0M $-31.0M $-23.0M $-14.0M Net Profit $-39.0M $-31.0M $-30.0M $-4.0M $-13.0M EPS $-7.52 $-4.39 $-4.15 $-0.48 $-1.20 Op Margin — -313.9% -1101.9% -239692.2% -1315.5%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $56.0M $44.0M $21.0M $22.0M $32.0M Total Liabilities $17.0M $33.0M $26.0M $28.0M $30.0M Cash $52.0M $35.0M $10.0M $16.0M $25.0M Borrowings $0 $0 $1.0M $1.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-29.0M $-18.0M $-39.0M $5.0M $-10.0M Investing Cash Flow $0 $0 $-1.0M $-1.0M $-1.0M Financing Cash Flow $1.0M $0 $6.0M $0 $-1.0M Net Cash Flow $47.0M $-17.0M $-24.0M $5.0M $9.0M Free Cash Flow $-29.0M $-18.0M $-39.0M $5.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -0.66 FCF Yield -101.62% Quick Ratio 0.99 Interest Coverage -55.72 Return 1Y -27.11% Return 3Y -80.17% Return 5Y -88.27%
Screens featuring this stock